VerifiedBiotechnology Research· Founded 2021

Charm Therapeutics

CHARM's lead program is a next-generation menin inhibitor for the treatment of acute myeloid leukemia (AML). Unlike first-generation menin inhibitors that rapidly lose potency due to menin resistance mutations, CHARM's candidates are specifically designed to maintain potency against all known clinical resistance mutations, potentially delivering the durable responses that patients desperately need.

7-day free trial · no credit card

London, United Kingdom35(11 to 50)2021charmtx.com LinkedIn

Verified contacts

31

available on Kipplo

LinkedIn employees

35

11 to 50 range

Open roles

—

no listings

Distinct roles

20

indexed titles

Tech stack

1

tools in use

Monthly traffic

156

organic / mo

Sign up free to see all 31 verified contacts at Charm Therapeutics

Free for 7 days · 50 credits · no card · only pay for verified records.

Decision-makers and verified team members

31 contacts with verified email or phone · masked until revealed.

Sign up free →

Showing 9 of 31 verified contacts

Top roles at Charm Therapeutics

20 distinct titles indexed · top 10 shown.

4senior scientist
3associate principal scientist
2senior scientist ii
1& ()
1(&)
1- &
1-,
1associate principle scientist
1crystallographer
1date entry representative
+10more titles

Sign up to unlock all 31 contacts at Charm Therapeutics

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up to reveal 31 verified contacts at Charm Therapeutics

7-day trial · no credit card · cancel anytime · only pay for verified records.

Sign up free See pricing

Trusted by sales, marketing, and GTM engineering teams.

Charm Therapeutics | Kipplo Discover